当前位置:首页>产品中心>单抗/多抗>Anti-galactose-deficient IgA1 Recombinant Antibody|抗半乳糖缺陷型IgA1重组抗体(靶标:半乳糖缺陷型IgA1)

Anti-galactose-deficient IgA1 Recombinant Antibody|抗半乳糖缺陷型IgA1重组抗体(靶标:半乳糖缺陷型IgA1)

  • 货号:RB9THV621013
  • 价格:面议
  • 点击:430
   一键复制产品信息 复制成功!

产品介绍

产品参数

形态Liquid
宿主种属Rat
克隆性Monoclonal
抗体亚型IgG2b, kappa
纯度>95% as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
内毒素水平Please contact with the lab for this information.
应用ELISA, IF, IHC
种属反应性Homo sapiens (Human)
靶标galactose-deficient IgA1, Gd-IgA1, IGHA1, Ig alpha-1 chain C region, Ig alpha-1 chain C region BUR, Ig alpha-1 chain C region TRO, Immunoglobulin heavy constant alpha 1
储存缓冲液0.01M PBS pH 7.4
稳定性和储存Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
重构方法Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
登录号P01876
背景信息

Immunoglobulin heavy constant alpha 1 (Gd-IgA1) is a ~42 kDa protein. Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain.

1. Schroeder, HW. et al. (2010) The Journal of allergy and clinical immunology 125, S41-52. PMID: 20176268
2. McHeyzer-Williams, M. et al. (2011) Nature reviews. Immunology 12, 24-34. PMID: 22158414
3. Teng, G. et al. (2007) Annual review of genetics 41, 107-20. PMID: 17576170
4. Kerr, MA. (1990) The Biochemical journal 271, 285-96. PMID: 2241915
备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Anti-Dulaglutide Neutralizing Antibody ELISA Kit|抗度拉糖肽中和抗体ELISA检测试剂盒(靶标:抗度拉糖肽中和抗体酶联免疫检测试剂盒) 426
Anti-Human CHRNA7 Recombinant Nanobody |抗人CHRNA7纳米抗体(靶标:人烟碱型乙酰胆碱受体α7亚基) 295
Anti-Carbonic anhydrase IX Recombinant Antibody|抗碳酸酐酶IX重组抗体(靶标:碳酸酐酶9) 607
Anti-Human CD326/EPCAM Recombinant Antibody|抗人CD326/EPCAM重组抗体(靶标:人上皮细胞黏附分子/CD326) 550
Anti-Human CD326/EPCAM Recombinant Antibody|抗人CD326/EPCAM重组抗体(靶标:人上皮细胞黏附分子/CD326) 453
Anti-Human SOST Recombinant Nanobody |抗人SOST纳米抗体(靶标:人硬骨素/Sclerostin) 595
Anti-Human FOLR1 Recombinant Nanobody |抗人FOLR1纳米抗体(靶标:人叶酸受体1) 612
Anti-Infliximab Neutralizing Antibody ELISA Kit|抗英夫利昔单抗中和抗体ELISA检测试剂盒(靶标:抗英夫利昔单抗中和抗体酶联免疫检测试剂盒) 509
Vedolizumab ELISA Kit|维多珠单抗ELISA检测试剂盒(靶标:维多珠单抗酶联免疫检测试剂盒) 396
Anti-Vedolizumab ELISA Kit|抗维多珠单抗ELISA检测试剂盒(靶标:抗维多珠单抗酶联免疫检测试剂盒) 520
Anti-Vedolizumab Neutralizing Antibody ELISA Kit|抗维多珠单抗中和抗体ELISA检测试剂盒(靶标:抗维多珠单抗中和抗体酶联免疫检测试剂盒) 411
Anti-Vedolizumab Polyclonal Antibody|抗维多珠单抗多克隆抗体(靶标:维多珠单抗多克隆抗体) 597
Anti-Influenza A virus (H7N9) M2e Polyclonal Antibody|抗甲型流感病毒(H7N9)M2e多克隆抗体(靶标:甲型流感病毒H7N9亚型M2蛋白胞外结构域) 595
Anti-Teriparatide Polyclonal Antibody|抗特立帕肽多克隆抗体(靶标:特立帕肽多克隆抗体) 700
Anti-TRSV 2C-CP/Coat Polyclonal Antibody|抗TRSV 2C-CP/衣壳多克隆抗体(靶标:烟草环斑病毒2C-衣壳蛋白) 459
Anti-Mouse CD5L Polyclonal Antibody|抗小鼠CD5L多克隆抗体(靶标:小鼠CD5分子样蛋白) 395
Anti-ASFV p15 Recombinant Antibody |抗ASFV p15重组抗体(靶标:非洲猪瘟病毒p15蛋白) 469
Anti-FMC63 scFv Monoclonal Recombinant Antibody |抗FMC63 scFv单克隆重组抗体(靶标:FMC63单链可变区片段) 343
Anti-Human ITPKB Polyclonal Antibody|抗人ITPKB多克隆抗体(靶标:人肌醇三磷酸3-激酶B) 327
Anti-Human LAMC3 Polyclonal Antibody|抗人LAMC3多克隆抗体(靶标:人层粘连蛋白γ3亚基) 362
总计 33037 个记录,共 1652 页,当前第 1636 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00